SMC GROUP

SMC Global Asset, Inc. was founded in 1990 under the core philosophy of contributing to the development of venture business. We currently focus on investment in biotechnology-related businesses and investment in North American businesses to facilitate global business expansion through our connections with enterprises aiming to expand overseas. We continue to stand with enterprises expanding globally and grow together with them, providing services built around a business structure focused on 3 fields: medical care, culture, and local urban development... SMC Laboratories, Inc. is a Tokyo-based nonclinical Contract Research Organization (CRO) that specializes in research on fibrosis and inflammation. We have more than 700 clients which include pharmaceutical companies, universities, and national medical institutions, and have assisted with clinical trial applications for more than 10 pipeline drugs, mainly for nonalcoholic steatohepatitis (NASH).

Also known as: SMC Global Asset, Inc., SMC Group International, Inc., SMC Laboratories, Inc.

Primary location: Ota Japan